VWR Corp (NASDAQ:VWR) saw a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 2,448,005 shares, a decline of 70.2% from the April 28th total of 8,222,154 shares. Approximately 2.9% of the company’s shares are sold short. Based on an average trading volume of 4,080,968 shares, the short-interest ratio is currently 0.6 days.

Several research analysts have weighed in on VWR shares. TheStreet upgraded VWR Corp from a “c” rating to a “b-” rating in a report on Wednesday, April 19th. Jefferies Group LLC boosted their price target on VWR Corp from $31.00 to $32.00 and gave the company a “buy” rating in a report on Monday, February 27th. Zacks Investment Research upgraded VWR Corp from a “hold” rating to a “buy” rating and set a $37.00 price target for the company in a report on Tuesday, May 16th. Finally, William Blair downgraded VWR Corp from an “outperform” rating to a “market perform” rating in a report on Monday, May 15th. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company. VWR Corp currently has an average rating of “Hold” and a consensus price target of $32.67.

Shares of VWR Corp (NASDAQ:VWR) opened at 32.87 on Friday. The stock has a market capitalization of $4.33 billion, a PE ratio of 29.35 and a beta of 1.13. VWR Corp has a 52 week low of $24.42 and a 52 week high of $37.25. The stock’s 50 day moving average is $30.55 and its 200 day moving average is $27.48.

VWR Corp (NASDAQ:VWR) last issued its quarterly earnings results on Friday, May 5th. The medical research company reported $0.44 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.41 by $0.03. The business had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.11 billion. VWR Corp had a net margin of 3.89% and a return on equity of 16.06%. The firm’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.40 EPS. Analysts anticipate that VWR Corp will post $1.83 EPS for the current fiscal year.

Several large investors have recently modified their holdings of VWR. Vanguard Group Inc. increased its stake in shares of VWR Corp by 5.3% in the first quarter. Vanguard Group Inc. now owns 6,827,046 shares of the medical research company’s stock valued at $192,523,000 after buying an additional 345,117 shares during the period. Harris Associates L P increased its stake in VWR Corp by 43.3% in the first quarter. Harris Associates L P now owns 5,250,960 shares of the medical research company’s stock worth $148,077,000 after buying an additional 1,587,214 shares during the last quarter. JPMorgan Chase & Co. increased its stake in VWR Corp by 79.2% in the first quarter. JPMorgan Chase & Co. now owns 4,531,105 shares of the medical research company’s stock worth $127,777,000 after buying an additional 2,002,306 shares during the last quarter. Acadian Asset Management LLC increased its stake in VWR Corp by 16.7% in the first quarter. Acadian Asset Management LLC now owns 4,438,055 shares of the medical research company’s stock worth $125,152,000 after buying an additional 635,873 shares during the last quarter. Finally, BlackRock Inc. increased its stake in VWR Corp by 4,641.8% in the first quarter. BlackRock Inc. now owns 4,072,333 shares of the medical research company’s stock worth $114,840,000 after buying an additional 3,986,452 shares during the last quarter.

ILLEGAL ACTIVITY WARNING: This piece of content was published by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/05/27/short-interest-in-vwr-corp-vwr-drops-by-70-2.html.

VWR Corp Company Profile

VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.

12 Month Chart for NASDAQ:VWR

Receive News & Ratings for VWR Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR Corp and related companies with MarketBeat.com's FREE daily email newsletter.